Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Prorok

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Journal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C Prorok
BMC Medical Research Methodology|April 12, 2003
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screeningStuart G Baker, Diane Erwin, Barnett S Kramer, et al.
European Urology|May 12, 2015
Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trialRobert L Grubb, Paul Pinsky, Philip C Prorok, et al.
Reviews on Recent Clinical Trials|August 5, 2015
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, ResultsJohn K Gohagan, Philip C Prorok, Peter Greenwald, et al.
Journal of Medical Screening|November 3, 2011
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)Barnett S Kramer, Christine D Berg, Denise R Aberle, et al.
Journal of Medical Screening|April 5, 2019
Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialPaul F Pinsky, Eric A Miller, Claire S Zhu, et al.
The New England Journal of Medicine|October 13, 2016
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening EffectivenessH Gilbert Welch, Philip C Prorok, A James O'Malley, et al.
Biometrics|September 2, 2004
Estimating the cumulative risk of a false-positive test in a repeated screening programJian-Lun Xu, Richard M Fagerstrom, Philip C Prorok, et al.
Lancet (London, England)|September 14, 2010
Flexible sigmoidoscopy to prevent colorectal cancerV Paul Doria-Rose, Chris Vinden, David F Ransohoff, et al.
Urologic Oncology|July 31, 2004
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promiseGerald L Andriole, Douglas Reding, Richard B Hayes, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C Prorok
BMC Medical Research Methodology|April 12, 2003
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screeningStuart G Baker, Diane Erwin, Barnett S Kramer, et al.
European Urology|May 12, 2015
Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trialRobert L Grubb, Paul Pinsky, Philip C Prorok, et al.
Reviews on Recent Clinical Trials|August 5, 2015
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, ResultsJohn K Gohagan, Philip C Prorok, Peter Greenwald, et al.
Journal of Medical Screening|November 3, 2011
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)Barnett S Kramer, Christine D Berg, Denise R Aberle, et al.
Journal of Medical Screening|April 5, 2019
Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialPaul F Pinsky, Eric A Miller, Claire S Zhu, et al.
The New England Journal of Medicine|October 13, 2016
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening EffectivenessH Gilbert Welch, Philip C Prorok, A James O'Malley, et al.
Biometrics|September 2, 2004
Estimating the cumulative risk of a false-positive test in a repeated screening programJian-Lun Xu, Richard M Fagerstrom, Philip C Prorok, et al.
Lancet (London, England)|September 14, 2010
Flexible sigmoidoscopy to prevent colorectal cancerV Paul Doria-Rose, Chris Vinden, David F Ransohoff, et al.
Urologic Oncology|July 31, 2004
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promiseGerald L Andriole, Douglas Reding, Richard B Hayes, et al.
Pageof 9